Invea Therapeutics
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $1.5M
Investors
- 1
About Invea Therapeutics
Based in Connecticut, US, and founded in 2021, Invea Therapeutics, Inc. is a biotechnology company that develops medicines designed for immune-mediated inflammatory disorders (IMIDs). The company was founded by its CEO and president, Krishnan Nandabalan. In April 2022, Invea Therapeutics, Inc. The company develops precision medicines for individuals suffering from gastrointestinal and hepatobiliary disorders. The firm employs AI to decode the intricate relationship known as the gut-brain axis (GBA) that integrates various types of data, encompassing biology, symptomatology, and pharmacology. Invea's focus on innate immunity, inflammasome biology, and neuroinflammation provides a precision medicine approach to address the root causes of disorders affected by the GBA. The company’s pipeline programs include INVA8001, INVA8002, INVA8003, and the discovery pipeline. The organization intends to go public on the Nasdaq (INAI).
Who invested in Invea Therapeutics
1 investor across 1 round
See all investors in Invea Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 7, 2022
Amount
$1.5M
Investors
Questions about Invea Therapeutics
Who invested in Invea Therapeutics?
Invea Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Invea Therapeutics raised?
Invea Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Invea Therapeutics last raise money?
Invea Therapeutics's most recent round on record is a Series A, in Apr 2022.
What does Invea Therapeutics do?
Based in Connecticut, US, and founded in 2021, Invea Therapeutics, Inc.
Where is Invea Therapeutics headquartered?
Invea Therapeutics is headquartered in Guilford, US.
Which VCs invest in companies like Invea Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Invea Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Invea Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.